[Changes in uptake of triglycerides due to ischemia induced by atrial pacing and angiotensin].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to M Nardini.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In order to obtain functional images of brain perfusion, we exploited a new concept, which is to take advantage of the short half-life of a radioactive tracer. Under continuous intracarotid infusion of a solution of Kr-81m (T1/2 = 13 sec; produced from its parent, 4.6-hr Rb-81), this tracer will never reach equilibrium within the brain because of the rapid radioactive decay. Its distribution will therefore reflect regional arrival of the nuclide, indicating regional cerebral blood flow rather than volume. During continuous infusion of Kr-81m, perfusion images can be obtained by simply collecting counts with a gamma camera and recording on Polaroid film. The procedure is readily repeatable in order to get images in multiple veiws or to follow minute-by-minute changes of cerebral perfusion.
Amantadine, administered at a dose of 200 mg/day, antagonized the extapyramidal symptomatology induced by neuroleptic drugs in fifteen psychiatric patients. Steady-state levels were reached within 4-7 days of treatment. Individual plasma levels ranged from 200-900 ng/ml. Apparent plasma half-lives varied from 10-28.5 h with an apparent VD of 200-400 litres. A significant relationship was found between the plasma levels of amantadine and the effects on the extrapyramidal symptomatology. The data suggest a direct effect of amantadine on dopaminergic receptors.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.